Description
HERZUMA (trastuzumab) is a biosimilar medication used to treat certain breast cancers that are HER2-positive. It's administered intravenously as an injection in a 420 mg dose. Manufactured by Celltrion Inc., it's a HER2/neu receptor antagonist that helps block cancer cell growth. This information was generated using AI and is provided for informational and research purposes only.
Resources
| Name |
Format |
Description |
Link |
|
21 |
Access the FDA dataset for Trastuzumab — ANDA 761106 submitted by Mylan Institutional LLC
|
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761106 |
Tags
- health-care
- drug-manufacturers
- drug
- pharmaceuticals
- medications